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1436Background: Atrial fibrillation (AF) after cardiac surgery is associated with increased morbidity and hospital
length of stay. Our objective was to determine whether a minimally invasive approach to isolated valve surgery
reduced the incidence of postoperative AF.
Methods: Patients without a history of arrhythmia, who underwent isolated aortic or mitral valve surgery
between January 2005 and August 2011, were included. The incidence of postoperative AF in those who under-
went a minimally invasive approach was compared with that of patients undergoing median sternotomy surgery.
Resource utilization was approximated on the basis of intensive care unit and total hospital lengths of stay.
Results: A total of 571 patients were identified (413 minimally invasive and 158 median sternotomy). No sig-
nificant differences in baseline characteristics existed between groups. The incidence of postoperative AF (25%
vs 37%; P ¼ .002), use of intraoperative blood products (52% vs 83%; P<.001), and prolonged intubation
(24 hours) (12% vs 20%; P ¼ .008) were significantly less in the minimally invasive group. The intensive
care unit and hospital lengths of stay were 45 hours (interquartile range [IQR], 28-66 hours) versus 53 hours
(IQR, 45-91 hours) (P<.001), and 5 days (IQR, 4-7 days) versus 8 days (IQR, 6-11 days) (P<.001) for the
minimally invasive and median sternotomy groups, respectively. Multivariable analysis revealed a decreased
risk of postoperative AF in patients undergoing minimally invasive surgery (odds ratio, 0.4; 95% confidence
intervals, 0.24-0.66; P<.001).
Conclusions: A minimally invasive approach for isolated valve surgery reduces postoperative AF and resource
use when compared with median sternotomy. (J Thorac Cardiovasc Surg 2013;146:1436-41)Postoperative atrial fibrillation (AF) is common after car-
diac surgery, occurring in 37% to 50% of patients undergo-
ing isolated valve surgery.1-3 In addition to the established
preoperative risk factors such as age, hypertension,
history of AF, chronic obstructive pulmonary disease, and
valvular heart disease,1,4 several operative variables
significantly affect the incidence of postoperative AF.
These include manipulation of the heart and pericardium
during surgery, prolonged cardiopulmonary bypass and
aortic crossclamp times, and postoperative inflammatory
effects.5,6 The development of postoperative AF is
associated with an increased risk of perioperative
morbidity, as well as prolonged hospital length of stay.7
In patients undergoing valve surgery, a minimally inva-
sive approach has been associated with less bleeding,
decreased wound infections and septic complications, and
faster postoperative recovery when compared withe Columbia University Division of Cardiologya and the Division of Cardiac
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The Journal of Thoracic and Cardiovascular Sura standard median sternotomy approach.8,9 These findings,
as well as reduction of in-hospital mortality in elderly pa-
tients, are leading to increased acceptance of minimally in-
vasive valve surgery as an alternative to standard median
sternotomy surgery.10-12
Whereas the association between median sternotomy
valve surgery and the development of postoperative AF
has been widely established, the effect of a minimally inva-
sive approach on postoperative AF remains less clear. Our
study aimed to analyze the effect of minimally invasive
valve surgery on the incidence of new-onset postoperative
AF in patients undergoing isolated aortic or mitral valve
surgery. We analyzed the outcomes of patients who under-
went minimally invasive surgery and compared them with
a cohort who underwent a median sternotomy approach.
METHODS
After obtaining approval from the Mount Sinai Medical Center Institu-
tional Review Board, we retrospectively evaluated all heart operations per-
formed at our institution between January 1, 2005, and August 31, 2011, to
identify patients who underwent isolated mitral or aortic valve surgery and
had no history of arrhythmia. Excluded were patients who had previous
cardiac surgery, those who had concomitant coronary artery bypass graft
surgery and/or surgery on another valve, active infective endocarditis, or
emergency surgery. The median sternotomy surgery was performed by
a group of 6 surgeons who used only this approach, whereas a single sur-
geon (J.L.) performed all the minimally invasive surgery.
All patients had their valvular lesions documented by diagnostic cath-
eterization and echocardiography, and all operative reports and echocar-
diograms were reviewed. The primary outcome was postoperative AF,gery c December 2013
Abbreviations and Acronyms
AF ¼ atrial fibrillation
CI ¼ confidence interval
IQR ¼ interquartile range
OR ¼ odds ratio
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gical technique time was compared on the basis of total cardiopulmonary
bypass and aortic crossclamp times. Resource use was approximated on
the basis of intensive care unit and total hospital lengths of stay. The def-
initions and variables selected were based on the Society of Thoracic Sur-
geons database definitions.
Technique for Minimally Invasive Mitral Valve
Surgery
All patients were placed in the supine position and underwent anesthetic
induction and intubation with a single-lumen endotracheal tube. A roll was
placed underneath the right scapula in patients undergoing a minimally in-
vasive mitral valve procedure. Every patient had a Swan-Ganz catheter
(Edwards LifeSciences, Irvine, Calif) and a radial arterial line placed. A
transesophageal echocardiogram Doppler probe was placed intraopera-
tively to evaluate the diseased valves, as well as to assess the postoperative
results.
In all cases, a femoral platform was used to establish cardiopulmonary
bypass. A 2- to 3-cm incisionwasmade in the inguinal crease. A 5-0 Prolene
polypropylene purse-string suture (Ethicon, Inc, Somerville, NJ) was placed
on the femoral artery and vein. After heparinization, a Seldinger technique
was used to cannulate the femoral vessels. The femoral artery was cannu-
lated with a 16F to 18F arterial cannula (Edwards LifeSciences), and the
femoral vein was cannulated with a 25F venous cannula (Medtronic BioMe-
dicus, Minneapolis, Minn). Transesophageal echocardiography was used to
aid in the placement of the venous cannula in the superior vena cava.
For the mitral valve procedures, a 5- to 6-cm skin incision was made in
the fourth to fifth intercostal space at the site of the anterior axillary line.
The mitral valve was accessed through the Waterston groove and then
through the atrial septum into the left atrium. A specially designed atrial
lift retractor and atrial exposure devicewas used for visualization of the mi-
tral valve, and mitral valve repair or replacement was carried out in the
standard fashion. The left atrial appendage was not ligated in any of the pa-
tients. A 4-0 Prolene polypropylene suturewas used to close the left atrium.
If significant peripheral vascular diseasewas present in patients undergoing
mitral valve procedures, then axillary artery cannulation was performed.
For aortic valve procedures, a 5- to 6-cm transverse right parasternal in-
cision was made over the second to third intercostal space. In all aortic
valve procedures, the second or third costochondral cartilage was trans-
ected to allow adequate exposure of the aorta. At the completion of the op-
eration, the rib was reattached to the sternum with a 1-cm metal plate
(Synthes Inc, West Chester, Pa) and a fiber wire was placed in a figure-
of-8 fashion. In all cases, the pericardium was opened above the phrenic
nerve and over the aorta to facilitate exposure. A transverse aortotomy
was performed to expose the aortic valve, and valve replacement was car-
ried out under direct vision with standard techniques. In aortic valve pro-
cedures, a left ventricular vent was inserted into the left ventricle via
a purse-string suture in the right superior pulmonary vein. If significant pe-
ripheral vascular disease had been present, then central aortic cannulation
would have been performed, which was not the case in any of the patients.
By means of transesophageal echocardiographic guidance, a retrograde
coronary sinus catheter was directly inserted through the incision, and
a purse-string suture was placed in the right atrium. Cardiopulmonary by-
pass was initiated at 32C to 36C using a closed membrane oxygenatorThe Journal of Thoracic and Carand roller pump. Venous drainage was augmented with vacuum assistance
applying negative pressures of 30 to 70 mm Hg as needed to decompress
the right heart. Transincisional direct aortic crossclamping was performed
with a flexible and retractable shaft crossclamp (Novare Surgical Systems,
Cupertino, Calif). One dose of cold blood cardioplegic solution was given
antegradely to establish electromechanical arrest of the heart. Thereafter,
cold blood cardioplegic solution was given retrogradely throughout the
procedure at 20- to 25-minute intervals. If retrograde cardioplegia was
not possible, a cannula was left in the ascending aorta to deliver antegrade
cardioplegia, or the heart was fibrillated. All procedures were performed
with specially designed long-shafted minimally invasive instruments
(Geister, Tuttlingen, Germany). Carbon dioxide was infused into the oper-
ative field during the entire procedure. Air from the heart was removed with
a needle in the root of the aorta and under transesophageal echocardio-
graphic guidance. The heart was not directly manipulated during deairing
maneuvers. If needed, the chest wall was compressed externally to aid in
deairing. With the heart empty, both atrial, and ventricular pacing wires
were placed. After cardiopulmonary bypass had been discontinued and
protamine administered, decannulation was performed. The purse-string
sutures were tied, and the femoral artery was directly repaired with 5-0 Pro-
lene polypropylene suture. A single chest tube was left in the pleural space.
For pain relief, all patients had an On-Q pain relief system inserted (I-Flow
Corporation, Lake Forest, Calif). Two catheters were placed in the intercos-
tal space to deliver 0.25% bupivicaine for 72 hours. The thoracotomy in-
cision was closed in the routine fashion.Statistical Methods
Continuous variables were expressed as the mean  1 standard devia-
tion or median and interquartile range (IQR). Variables with a normal dis-
tribution were compared by use of an independent t test, whereas those
variables that did not exhibit a normal distribution were compared with
a Mann-Whitney U test. A c2 analysis was used to compare dichotomous
variables. Comorbidities and risk factors that could have a significant influ-
ence on the development of postoperative AF, including surgical proce-
dural variables, were evaluated by univariable analysis. Those with
a P value of .25 or less were included, in addition to established risk factors
for AF, in a logistic regression analysis to determine their independent ef-
fects. The statistical analyses were performed using SPSS version 17
(SPSS, Inc, Chicago, Ill).RESULTS
A total of 571 patients were identified, 413 in the
minimally invasive group and 158 in the median sternot-
omy group. There were no significant differences in
baseline preoperative characteristics between the 2 groups
(Table 1).
In the entire cohort of patients, 160 had postoperative AF
and 411 did not. The mean age was 72.5  9.5 years versus
64.5  14.2 years (P<.001), and the median preoperative
creatinine value was 1.0 mg/dL (IQR, 0.8-1.2 mg/dL) ver-
sus 0.91 mg/dL (IQR, 0.8-1.1 mg/dL) (P¼ .005) in patients
in whom postoperative AF developed versus those in
whom it did not, respectively. Patients with postoperative
AF had a higher incidence of older age (65 years; 81%
vs 56%; P < .001), diabetes mellitus (37% vs 19%;
P< .001), hypertension (90% vs 82%; P ¼ .02), prior
stroke (9% vs 5%; P ¼ .04), and preoperative beta-
blocker use (64% vs 50%; P ¼ .002) as compared with
those without postoperative AF (Table 2).diovascular Surgery c Volume 146, Number 6 1437
TABLE 1. Baseline characteristics of the minimally invasive versus
median sternotomy groups
Variables
Minimally
invasive
(n ¼ 413)
Median
sternotomy
(n ¼ 158)
P
value
Age (mean  SD) 67.2  14 65.7  12.4 .26
Age>65 y 267 (65%) 91 (58%) .12
Female gender 222 (54%) 91(58%) .41
Body mass index (median, IQR) 27 (24-30) 28 (24-31) .1
Diabetes mellitus 93 (23%) 44 (28%) .18
Hypertension 345 (84%) 137 (87%) .35
Previous myocardial infarction 49 (12%) 13 (8%) .21
Previous stroke 24 (6%) 11 (7%) .61
Chronic obstructive pulmonary
disease
100 (24%) 44 (28%) .37
Preoperative beta-blocker 224 (54%) 83 (53%) .72
Preoperative creatinine (median,
IQR)
0.94 (0.8-1.1) 0.93 (0.8-1.2) .71
Ejection fraction (mean  SD) 56  10 54  12 .13
Ejection fraction  30% 17 (4%) 12 (8%) .09
SD, Standard deviation; IQR, interquartile range.
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placements and 183 (44%) versus 52 (33%) mitral valve
operations in the minimally invasive versus median sternot-
omy groups, respectively (P ¼ .01 for both). Of the mitral
valve operations, there were 121 (66%) versus 28 (54%) re-
pairs and 62 (34%) versus 24 (46%) replacements in the
minimally invasive and median sternotomy groups, respec-
tively (P¼ .1 for both). The type of valvular disease was not
significantly different between the 2 groups. For aortic
valve surgery in the minimally invasive group, the types
of disease were 35 (59%) senile degenerative aorticTABLE 2. Baseline characteristics in patients with postoperative AF
versus no AF
Variables
Postoperative
AF (n ¼ 160)
No postoperative
AF (n ¼ 411)
P
value
Age (mean  SD) 72.5  9.5 64.5  14.2 <.001
Age>65 y 130 (81%) 228 (56%) <.001
Female gender 97 (61%) 216 (53%) .08
Body mass index (median, IQR) 28 (24-30) 27 (24-30) .39
Diabetes mellitus 59 (37%) 78 (19%) <.001
Hypertension 144 (90%) 338 (82%) .02
Previous myocardial infarction 18 (11%) 44 (11%) .85
Previous stroke 15 (9%) 20 (5%) .04
Chronic obstructive pulmonary
disease
43 (27%) 101 (25%) .57
Preoperative beta-blocker 103 (64%) 204 (50%) .002
Preoperative creatinine (median,
IQR)
1.0 (0.8-1.2) 0.91 (0.8-1.1) .005
Ejection fraction
(%, mean  SD)
55  11 56  11 .66
Ejection fraction  30% 7 (4%) 22 (5%) .63
AF, Atrial fibrillation; SD, standard deviation; IQR, interquartile range.
1438 The Journal of Thoracic and Cardiovascular Surstenosis, 55 (24%) bicuspid aortic stenosis, 32 (14%) bi-
cuspid aortic insufficiency, and 8 (3%) aortic insufficiency
owing to aortic root dilatation or aortic valve leaflet pro-
lapse; for mitral valve surgery, the types of diseases were
103 (56.4%) myxomatous mitral regurgitation, 41
(22.3%) functional mitral regurgitation, and 39 (21.3%)
rheumatic mitral regurgitation. For median sternotomy,
the aortic valve diseases were 58 (55%) senile degenerative
aortic stenosis, 29 (27%) bicuspid aortic stenosis, 16 (15%)
bicuspid aortic insufficiency, and 3 (3%) aortic insuffi-
ciency owing to aortic root dilatation or aortic valve leaflet
prolapse; for mitral valve surgery, they were 30 (58%) myx-
omatous mitral regurgitation, 11 (21%) functional mitral
regurgitation, and 11 (21%) rheumatic mitral regurgitation.
The mean cardiopulmonary bypass time was 117 37 min-
utes in the minimally invasive group versus 89 40minutes
in the median sternotomy group (P<.001) and the mean
aortic crossclamp time was 87  31 minutes versus 67 
32 minutes (P< .001). For the minimally invasive group
versus the median sternotomy group, respectively, the inci-
dence of perfusion time greater than 100 minutes was 63%
versus 29% (P<.001), use of intraoperative blood products
was 52% versus 83% (P<.001), incidence of prolonged in-
tubation (24 hours) was 12% versus 20% (P¼ .008), and
intensive care unit readmission was 2% versus 6%
(P ¼ .02). The total intensive care unit length of stay was
45 hours (IQR, 28-66 hours) versus 53 hours (IQR, 45-91
hours) (P<.001), and the total hospital length of stay was
5 days (IQR, 4-7 days) versus 8 days (IQR, 6-11 days)
(P<.001) in the minimally invasive versus median sternot-
omy groups (Table 3).
Postoperative AF occurred in 25% of patients in the min-
imally invasive group versus 37% of patients in the median
sternotomy group (P ¼ .002). On analysis, the incidence of
postoperative AF in the minimally invasive versus the me-
dian sternotomy groups was 26% versus 39% of aortic
valve replacements (P ¼ .02) and 22% versus 35% ofTABLE 3. Operative results and clinical outcomes
Variables
Minimally
invasive
(n ¼ 413)
Median
sternotomy
(n ¼ 158)
P
value
Mortality 4 (0.9%) 1 (0.6%) .7
Bleeding requiring reoperation 7 (1.7%) 4 (2.5%) .52
Deep wound infection 0 1 (0.6%) .11
Stroke 4 (0.9%) 1 (0.6%) .7
Prolonged intubation (>24 h) 48 (12%) 32 (20%) .008
Intensive care unit length of stay
(h, median, IQR)
45 (28-66) 53 (45-91) <.001
Intensive care unit readmission 10 (2%) 10 (6%) .02
Hospital length of stay (d, median,
IQR)
5 (4-7) 8 (6-11) <.001
Postoperative AF 101 (25%) 59 (37%) .002
SD, Standard deviation, IQR, interquartile range; AF, atrial fibrillation.
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TABLE 4. Multivariable predictors of postoperative AF
Variables
95% CI
Odds ratio Lower CI Upper CI P value
Minimally invasive surgery 0.4 0.24 0.66 <.001
Age 1.07 1.05 1.1 <.001
Preoperative beta-blocker 1.73 1.12 2.69 .01
Female gender 1.77 1.13 2.77 .01
Prolonged ventilation (>24 h) 2.03 1.19 3.46 .01
Diabetes mellitus 2.28 1.43 3.62 .001
Hypertension, chronic obstructive pulmonary disease, myocardial infarction, ejection
fraction less than 35%, mitral valve surgery, cardiopulmonary bypass time greater
than 100, and use of intraoperative blood products were included in the multivariable
analysis and were not significant. AF, Atrial fibrillation; CI, confidence interval.
TABLE 5. Postoperative outcomes in patients with AF
Variables AF (n ¼ 160) AF (n ¼ 411)
P
value
In-hospital mortality 0 5 (1%) .16
Bleeding necessitating reoperation 5 (3%) 6 (2%) .19
Deep wound infection 0 1 (0.2%) .53
Prolonged intubation 38 (24%) 42 (10%) <.001
Acute renal failure 6 (4%) 5 (1%) .05
Sepsis 5 (3%) 5 (1%) .12
Pneumonia 11 (7%) 10 (2%) .01
Reintubation 17 (11%) 13 (3%) <.001
Stroke 1 (0.6%) 4 (1%) .69
Intensive care unit length of stay
(h, median, IQR)
46 (29-64) 53 (44-98) <.001
Hospital length of stay
(d, median, IQR)
5 (4-7) 8 (6-11) <.001
AF, Atrial fibrillation; IQR, interquartile range.
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vealed minimally invasive surgery (odds ratio [OR], 0.4;
95% confidence intervals [CI], 0.24-0.66; P< .001), age
(OR, 1.07; 95% CI, 1.05-1.1; P < .001), preoperative
beta-blocker use (OR, 1.73; 95% CI, 1.12-2.69; P ¼ .01),
female gender (OR, 1.77; 95%CI, 1.13-2.77; P¼ .01), pro-
longed ventilation for 24 hours or more (OR, 2.03; 95% CI,
1.19-3.46; P ¼ .01), and diabetes mellitus (OR, 2.28; 95%
CI, 1.43-3.62; P ¼ .001) to be independent predictors of
postoperative AF (Table 4).
Among patients who had postoperative AF, there was an
increased incidence of prolonged intubation (24 hours)
(24% vs 10%; P<.001), acute renal failure (4% vs 1%;
P ¼ .05), pneumonia (7% vs 2%; P ¼ .01), and reintuba-
tion (11% vs 3%; P<.001) as compared with patients with-
out postoperative AF. The total intensive care unit length of
stay was 53 hours (IQR, 44-98 hours) versus 46 hours (IQR,
29-64) (P<.001), and the total hospital length of stay was 8
days (IQR, 6-11 days) versus 5 days (IQR, 4-7 days)
(P<.001) when comparing patients who had postoperative
AF versus those without postoperative AF (Table 5).DISCUSSION
AF after cardiac surgery remains a common postopera-
tive complication and is associated with significant morbid-
ity. Patients in whom AF develops postoperatively are also
at increased risk of myocardial infarction, congestive heart
failure, renal injury, sepsis, and longer intensive care unit
and hospital lengths of stay.4,7 In-hospital stroke is nearly
2 times more likely, and in-hospital and late-term mortality
are increased by more than 50%.7 Furthermore, in patients
who have undergone coronary artery bypass grafting sur-
gery, it is estimated that postoperative AF increases hospital
length of stay by 5 days and total hospital cost by more than
$10,000 per patient.13 In the present study, we hypothesized
that by reducing surgical trauma and inflammation and im-
proving postoperative recovery, a minimally invasive ap-
proach to valve surgery would decrease the incidence of
postoperative AF when compared with standard median
sternotomy surgery.The Journal of Thoracic and CarOur study demonstrated that in patients undergoing iso-
lated valve surgery, a minimally invasive approach provides
an overall 60% reduced risk of developing postoperative
AF despite, paradoxically, significantly longer cardiopul-
monary bypass and aortic crossclamp times, which have
been shown in prior studies to be risk factors for develop-
ment of postoperative AF.5,14 Bleeding necessitating
transfusion of blood products and prolonged mechanical
ventilation, both independent predictors of AF
development after cardiac surgery,15,16 were reduced by
37% and 40%, respectively, in patients undergoing
minimally invasive surgery, perhaps explaining the
paradox. The downstream effects of AF prevention were
multiple. Patients who underwent minimally invasive
surgery had a 66% reduction in intensive care unit
readmission, a 15% reduction in total intensive care unit
length of stay, and a 38% reduction in total hospital
length of stay. When coupling these results with the
longer length of hospitalization and postoperative
complications observed in patients who had postoperative
AF, it is very likely that performing valve surgery via
a minimally invasive approach had a significant impact on
resource use and total health care cost.
The data regarding minimally invasive valve surgery and
its effect on postoperative AF are equivocal. A meta-
analysis of 10 studies byMurtuza and associates,17 which in-
cluded 2262 patients undergoing aortic valve replacement,
found no difference in the incidence of postoperative AF or
surrogate outcome measures such as stroke and intensive
care unit and hospital lengths of stay between patients under-
going minimally invasive versus median sternotomy valve
surgery. A separate meta-analysis and systematic review by
Cheng and colleagues,18 concerning 8 studies with a total
of 10,347 patients, found that minimally invasive mitral
valve surgery was associated with an 18% reduction
in postoperative AF when compared with a conventionaldiovascular Surgery c Volume 146, Number 6 1439
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duction in the incidence of postoperative AF when using
a minimally invasive approach for isolated valve surgery.
This was driven by a significant decrease in postoperative
AF among patients undergoing aortic valve replacement
and a strong trend toward less postoperative AF in those un-
dergoing mitral valve surgery. The reduction in AF noted
with the minimally invasive approach may be due to de-
creased trauma leading to a reduction in inflammation. How-
ever, presently there are not sufficient data to make firm
conclusions as to the exact mechanism of this reduction.
In addition to age and prolonged ventilation, which are
widely established risk factors for the development of AF
after cardiac surgery, we identified several independent pre-
dictors of postoperative AF.1,4,16 First, preoperative beta-
blocker use was associated with a 73% increased risk of
postoperative AF. When compared with patients who
were not receiving preoperative beta-blockers, patients on
beta-blocker treatment were older (68.6  12.8 years vs
64.6  14.1 years; P ¼ .02) and had a higher incidence of
hypertension (95% vs 72%; P<.001), prior myocardial in-
farction (14% vs 7%; P ¼ .009), and at least moderate left
ventricular systolic dysfunction (ejection fraction  35%,
12% vs 3%; P<.001). All of these have been shown to in-
crease the risk of AF after cardiac surgery, thus confounding
the analysis of beta-blocker use and AF.1,4,16,19,20
Furthermore, sympathetic tone and right atrial
norepinephrine levels are increased acutely after cardiac
surgery.21 Second, women were observed to have a 77% in-
creased risk of postoperative AF. When compared with
male patients, women had significantly longer cardiopul-
monary bypass (116  40 vs 102  38 minutes; P<.001)
and aortic crossclamp times (87  32 vs 75  31 minutes;
P<.001), and it has been postulated that prolonged ische-
mia from inadequate atrial cooling and myocardial protec-
tion during cardioplegia triggers AF in vulnerable
patients.5,14,22 Women also had a greater incidence of at
least moderate left ventricular systolic dysfunction when
compared with men (ejection fraction  35%; 11% vs
4%; P ¼ .004), which has been shown to be an
independent predictor of postoperative AF.20 Finally, dia-
betic patients had a greater than 2-fold increase in the risk
of postoperative AF. Diabetes mellitus has been established
as a strong independent predictor of AF development. Al-
though the exact mechanism is not known, chronic micro-
vascular ischemia and metabolic abnormalities are likely
causes.23 Interestingly, in patients undergoing surgery for
mitral valve disease and in those with a left ventricular ejec-
tion fraction less than 35%, 2 subgroups of patients who
historically have been observed to be at increased incidence
of postoperative AF,20,24 we observed no significant
association between surgery and AF development. The
lower incidence of AF in the patients who had mitral
valve surgery may be due to the fact that, when compared1440 The Journal of Thoracic and Cardiovascular Surwith patients undergoing aortic valve replacement, they
were younger (63.0 þ 13.9 years vs 69.4  12.7 years;
P<.001), were less likely to have diabetes mellitus (14%
vs 31%; P < .001), were less likely to have
a cardiopulmonary bypass time exceeding 100 minutes
(46% vs 59%; P ¼ .002), and had less postoperative
renal failure (0.4% vs 3%; P ¼ .03), and thus were less
prone to the development of AF. The lack of an increased
incidence of AF in patients with a left ventricular ejection
fraction of less than 35% may be due to the fact that in
this subgroup of patients preoperative beta-blocker use
was far more common as compared with the remainder of
the cohort (80% vs 52%; P< .001) and therefore may
have been better protected.
The main limitation of our study is that it is a retrospec-
tive, single-center study. The surgical approaches were per-
formed by 2 different teams of surgeons, which introduces
a potential uncontrollable confounder. Furthermore, all
minimally invasive operations were performed by a single
surgeon, who is the study’s senior author (J.L.). Finally,
comparison of the surgical techniques was limited to in-
hospital outcomes.
In conclusion, in patients without a history of arrhythmia,
a minimally invasive surgical approach for aortic or mitral
valve surgery substantially reduces the incidence of postop-
erative AF. Furthermore, this likely has a significant impact
on health care resource utilization. This approach should be
considered as an alternative to standard median sternotomy
valve surgery.
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